AQP4+ NMOSD
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Safety and Tolerability Study of CC- 97540 (BMS-086353) in Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica Patients (NCT07573332) | University of Texas Southwestern Medical Center | 2026-09-01 |
| Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies (NCT05966467) | Alexion Pharmaceuticals, Inc. | 2024-02-01 |
Track AQP4+ NMOSD automatically
Every clearance here is in the API, with alerts when new ones post.